Mesenchymal Cell News Volume 14.44 | Nov 8 2022

    0
    25








    2022-11-07 | MESCN 14.44


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.44 – 8 November, 2022
    TOP STORY

    Mesenchymal Stromal Cell Spheroids in Sulfated Alginate Enhance Muscle Regeneration

    Scientists used sulfated alginate hydrogels loaded with mesenchymal spheroids to aid in the regeneration of a rat muscle crush injury.
    [Acta Biomaterialia]

    Full ArticleGraphical Abstract
    ON1104SM-Small-Molecules-Wallchart-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    SIRT2 Promotes the Viability, Invasion, and Metastasis of Osteosarcoma Cells by Inhibiting the Degradation of Snail

    The viability, migration, and invasion of osteosarcoma cells were inhibited by knockdown of SIRT2 and were enhanced by overexpression of SIRT2.
    [Cell Death & Disease]

    Full Article

    Paeoniflorin Drives the Immunomodulatory Effects of Mesenchymal Stem Cells by Regulating Th1/Th2 Cytokines in Oral Lichen Planus

    Investigators explored the immunomodulatory effect of paeoniflorin in MSCs and the potential involvement of Th1/Th2 cytokines in oral lichen planus.
    [Scientific Reports]

    Full Article

    Donor Age Effects on In Vitro Chondrogenic and Osteogenic Differentiation Performance of Equine Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stromal Cells

    The authors identified the effect of donor age on the chondrogenic and osteogenic differentiation performance of equine bone marrow- and adipose tissue-MSCs in vitro.
    [BMC Veterinary Research]

    Full Article

    Extracellular Matrix Protein Gelatin Provides Higher Expansion, Reduces Size Heterogeneity, and Maintains Cell Stiffness in a Long-Term Culture of Mesenchymal Stem Cells

    Investigators found that cells on plates coated with ECM proteins had much higher proliferation compared to the regular tissue culture plates.
    [Tissue and Cell]

    Abstract

    Blockade of FGF2/FGFR2 Partially Overcomes Bone Marrow Mesenchymal Stromal Cells Mediated Progression of T Cell Acute Lymphoblastic Leukemia

    Notch1-induced T cell acute lymphoblastic leukemia (T-ALL) mice models were used and dynamic alterations of bone marrow-MSCs with increased cell viability during T-ALL development were observed.
    [Cell Death & Disease]

    Full Article

    Drug-Based Mobilisation of Mesenchymal Stem/Stromal Cells Improves Cardiac Function Post Myocardial Infarction

    Researchers reported that endogenous MSCs mobilized into the circulation at day 5 post myocardial infarction in male Lewis rats.
    [Disease Models & Mechanisms]

    Full Article

    LC-MS/MS-Based Serum Proteomics Reveals a Distinctive Signature in a Rheumatoid Arthritis Mouse Model after Treatment with Mesenchymal Stem Cells

    To clarify the mechanism involved in effects of MSCs on rheumatoid arthritis (RA), proteomic profiling was performed using an RA mouse model before and after treatment with MSCs.
    [PLoS One]

    Full Article

    The Effects of Mesenchymal Stromal Cells and Platelet-Rich Plasma Treatments on Cutaneous Wound Healing

    Researchers studied the effect of MSC on skin wound healing and utilized an experimental murine model of full-thickness wounds. Wounds were treated with human bone marrow-MSC contained in a platelet-rich plasma clot.
    [Archives of Dermatological Research]

    Abstract
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Reciprocal Regulation of Mesenchymal Stem Cells and Immune Responses

    Scientists discuss the characteristics and functions of MSCs under different pathophysiological conditions and highlight how the immunomodulatory functions of MSCs are altered in accordance with the inflammatory cues.
    [Cell Stem Cell]

    Abstract

    Mesenchymal Stromal Cells in the Thymus

    The author outlines the current views on MSCs in the thymus, particularly highlighting the newly discovered function of thymic fibroblasts in T cell repertoire selection.
    [Inflammation and Regeneration]

    Full Article
    INDUSTRY AND POLICY NEWS

    LUMC to Fund New Clinical Trial of Cynata’s Cymerus™ MSCs in Kidney Transplantation

    Cynata Therapeutics Limited announced that the Leiden University Medical Center (LUMC) is funding an important clinical trial to investigate Cynata’s Cymerusâ„¢ MSCs as a treatment for renal graft rejection and to potentially reduce the requirement for anti-rejection drugs.
    [Cynata Therapeutics Limited]

    Press Release

    US Agency Seeks to Phase Out Animal Testing

    The US FDA had set out proposals for the New Alternative Methods Program that will focus on replacing, reducing, and refining the use of laboratory animals through the adoption of cutting-edge alternative methods.
    [Nature News]

    Press Release
    FEATURED EVENT

    Infections in Pregnancy: Pathogenic Mechanisms, Experimental Advances and Clinical Strategies

    January 22 – 25, 2022
    Santa Fe, New Mexico, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Tumor Biology

    Institute for Tumor Biology and Experimental Therapy – Frankfurt, Germany

    Postdoctoral Researcher – Stem Cell Therapy for Osteoarthritis

    NUI Galway – Galway, Ireland

    Postdoctoral Position – Joint and Articular Cartilage Homeostasis

    Harvard Medical School – Boston, Massachusetts, United States

    Postdoctoral Fellow – Mammalian Morphogenesis

    UC San Francisco – San Francisco, California, United States

    Postdoctoral Scientist – Cancer Regulators

    University of Texas Health Science Center at Houston – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter